about
Pancreatic cancerSoluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control studyGeneration and nuclear translocation of sumoylated transmembrane fragment of cell adhesion molecule L1.Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissuesTenascin-C serum levels and its prognostic power in non-small cell lung cancer.Lectin Histochemistry for Metastasizing and Non-metastasizing Cancer Cells.HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer.COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer.Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.Proteolytic cleavage of transmembrane cell adhesion molecule L1 by extracellular matrix molecule Reelin is important for mouse brain development.Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in miceFOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomasSystematic analysis of the human tumor cell binding to human vs. murine E- and P-selectin under static vs. dynamic conditionsBiperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancerProtein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC)
P50
Q27005724-37A0A429-B1FF-4C81-948F-6EA11E79F730Q33421074-18C34079-8F6B-4DD2-882E-BB1146DA7D00Q36006779-12B69E48-A6FB-447A-A655-982A357615C2Q36796294-B3454EB3-105A-47C2-BDC0-21D180C00975Q37190491-9C66F9B5-BDA7-4E51-8767-19131AD0C4B5Q38289185-F4EBA61B-4B65-41A8-AC4F-2C85687D4D45Q38726674-86103F7E-A351-4EC6-A250-350D6F67A2F7Q38869978-56DE050E-347D-484B-B29D-7A5164260645Q39021023-E4B12DD1-C4DD-4E51-8E7A-322A3B04836DQ39026693-B22B16B9-F5BB-4013-89E3-C18771B22951Q45897411-403524C8-DA46-4A7B-BB00-E2233766BC36Q47114764-0B6023D9-8FB1-4911-A338-3F6566F6487BQ50059039-DC9E19B5-FBF5-470C-8873-B911C94D6B3AQ57283775-C6CD3776-9107-4FC1-8E2A-8CE2CB56B16FQ59811797-545225ED-3822-4CF2-8A59-44077079B54FQ89901242-0CD77686-01B2-4BA0-A519-BCE786D639C4Q91770002-40B983DC-B7BC-489A-8867-C818A982C300Q92359163-CC5E3A99-966E-454B-BF27-432538FF0291
P50
description
researcher ORCID ID = 0000-0002-2984-6515
@en
wetenschapper
@nl
name
Gerrit Wolters-Eisfeld
@ast
Gerrit Wolters-Eisfeld
@en
Gerrit Wolters-Eisfeld
@es
Gerrit Wolters-Eisfeld
@nl
type
label
Gerrit Wolters-Eisfeld
@ast
Gerrit Wolters-Eisfeld
@en
Gerrit Wolters-Eisfeld
@es
Gerrit Wolters-Eisfeld
@nl
prefLabel
Gerrit Wolters-Eisfeld
@ast
Gerrit Wolters-Eisfeld
@en
Gerrit Wolters-Eisfeld
@es
Gerrit Wolters-Eisfeld
@nl
P106
P1153
55221833200
P31
P496
0000-0002-2984-6515